Efficacy of platelet-rich plasma as an adjuvant to surgical carpal ligament release: a prospective, randomized controlled clinical trial

Carmen Trull-Ahuir, Diego Sala, Joaquín Chismol-Abad, Marian Vila-Caballer, Juan Francisco Lisón, Carmen Trull-Ahuir, Diego Sala, Joaquín Chismol-Abad, Marian Vila-Caballer, Juan Francisco Lisón

Abstract

The purpose of this study is to evaluate the efficiency of local platelet-rich plasma (PRP) injection as an adjuvant treatment after carpal ligament release. We conducted a prospective randomized, triple-blinded, controlled trial. Fifty participants with mild to extreme carpal tunnel syndrome (CTS) were randomly assigned either to the PRP (n = 25) or the platelet-poor plasma (PPP, n = 25) group. After performing open surgical release of the carpal ligament, the inside of the carpal tunnel was irrigated with 3 mL of PRP or PPP according to each participant's group allocation. The primary outcome was hand grip strength (HGS). Secondary outcomes were the time taken off work after surgery (in days) and scores on the Wong-Baker Faces Scale, Boston Carpal Tunnel Questionnaire, and Southampton Wound Assessment Scale. We evaluated patients before treatment and at 6-weeks. As expected, the pain levels, symptom severity, and functional status improved in all the patients after surgery. However, intragroup analysis revealed that only the participants in the PRP group had regained their pre-operative HGS levels at 6-weeks follow-up. These findings indicate that PRP is an effective adjuvant treatment in patients with mild to severe CTS who require surgery.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Patient wound after surgical carpel ligament release with a semi-permeable occlusive adhesive dressing which was then covered with a compression bandage.
Figure 2
Figure 2
Flow of participants through the trial.

References

    1. Atroshi I. Prevalence of Carpal Tunnel Syndrome in a General Population. JAMA. 1999;282:153. doi: 10.1001/jama.282.2.153.
    1. Ghasemi-rad M. A handy review of carpal tunnel syndrome: From anatomy to diagnosis and treatment. World J. Radiol. 2014;6:284. doi: 10.4329/wjr.v6.i6.284.
    1. Keir PJ, Rempel DM. Pathomechanics of Peripheral Nerve Loading. J. Hand Ther. 2008;18:259–269. doi: 10.1197/j.jht.2005.02.001.
    1. Cranford CS, Ho JY, Kalainov DM, Hartigan BJ. Carpal tunnel syndrome. J. Am. Acad. Orthop. Surg. 2007;15:537–48. doi: 10.5435/00124635-200709000-00004.
    1. Newington L, Harris EC, Walker-Bone K. Carpal tunnel syndrome and work. Best Pract. Res. Clin. Rheumatol. 2015;29:440–453. doi: 10.1016/j.berh.2015.04.026.
    1. Padua L, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15:1273–1284. doi: 10.1016/S1474-4422(16)30231-9.
    1. Aroori S, Spence RAJ. Carpal tunnel syndrome. Ulster Med. J. 2008;77:6–17.
    1. Turner A, Kimble F, Gulyás K, Ball J. Can the outcome of open carpal tunnel release be predicted?: a review of the literature. ANZ J. Surg. 2010;80:50–54. doi: 10.1111/j.1445-2197.2009.05175.x.
    1. Middleton SD, Anakwe RE. Carpal tunnel syndrome. BMJ. 2014;349:g6437–g6437. doi: 10.1136/bmj.g6437.
    1. Boya H, Özcan Ö, Özteki̇n HH. Long-term complications of open carpal tunnel release. Muscle Nerve. 2008;38:1443–1446. doi: 10.1002/mus.21068.
    1. Anjayani S, et al. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int. J. Dermatol. 2014;53:109–113. doi: 10.1111/ijd.12162.
    1. Sánchez M, Yoshioka T, Ortega M, Delgado D, Anitua E. Ultrasound-guided platelet-rich plasma injections for the treatment of common peroneal nerve palsy associated with multiple ligament injuries of the knee. Knee Surgery, Sport. Traumatol. Arthrosc. 2014;22:1084–1089. doi: 10.1007/s00167-013-2479-y.
    1. Scala M, et al. The use of platelet-rich plasma gel in patients with mixed tumour undergoing superficial parotidectomy: a randomized study. In Vivo. 2014;28:121–4.
    1. Malahias MA, Johnson EO, Babis GC, Nikolaou VS. Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome. Neural Regen. Res. 2015;10:1856–1859. doi: 10.4103/1673-5374.165322.
    1. Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E. Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J. Plast. Surg. Hand Surg. 2017;51:301–305. doi: 10.1080/2000656X.2016.1260025.
    1. Wu YT, et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, singleblind controlled trial. Sci. Rep. 2017;7:1–11. doi: 10.1038/s41598-016-0028-x.
    1. Malahias MA, et al. Platelet-rich plasma ultrasound-guided injection in the treatment of carpal tunnel syndrome: A placebo-controlled clinical study. J. Tissue Eng. Regen. Med. 2018;12:e1480–e1488. doi: 10.1002/term.2566.
    1. Güven, S. C., Özçakar, L., Kaymak, B., Kara, M. & Akıncı, A. Short‐term effectiveness of platelet‐rich plasma in carpal tunnel syndrome: A controlled study. J. Tissue Eng. Regen. Med. 13, 709–714, 10.1002/term.2815 (2019).
    1. Atwa, E. T., Esh, A. M., Abd El Al, I. T. & Awad, Y. M. Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome: Clinical and electrophysiological study. Egypt. Rheumatol. 10.1016/j.ejr.2018.07.008 (2018)
    1. Malahias M-A, et al. Platelet-rich plasma injections for carpal tunnel syndrome: a systematic and comprehensive review. Eur. J. Orthop. Surg. Traumatol. 2019;29:1–8. doi: 10.1007/s00590-018-2278-8.
    1. Moher D, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869–c869. doi: 10.1136/bmj.c869.
    1. Padua L, et al. Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurol. Scand. 1997;96:211–7. doi: 10.1111/j.1600-0404.1997.tb00271.x.
    1. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J. Hand Surg. Am. 1984;9:222–6. doi: 10.1016/S0363-5023(84)80146-X.
    1. Wong, D. L. Whaley & Wong’s nursing care of infants and children. (Mosby, 1999).
    1. Levine DW, et al. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J. Bone Joint Surg. Am. 1993;75:1585–92. doi: 10.2106/00004623-199311000-00002.
    1. Oteo-Álvaro Á, Marín MT, Matas JA, Vaquero J. Validación al castellano de la escala Boston Carpal Tunnel Questionnaire. Med. Clin. (Barc). 2016;146:247–253. doi: 10.1016/j.medcli.2015.10.013.
    1. Bailey IS, et al. Community surveillance of complications after hernia surgery. BMJ. 1992;304:469–71. doi: 10.1136/bmj.304.6825.469.
    1. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of Growth Factor and Platelet Concentration From Commercial Platelet-Rich Plasma Separation Systems. Am. J. Sports Med. 2011;39:266–271. doi: 10.1177/0363546510387517.
    1. Sundman EA, Cole BJ, Fortier LA. Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma. Am. J. Sports Med. 2011;39:2135–2140. doi: 10.1177/0363546511417792.
    1. Magalon J, et al. Characterization and Comparison of 5 Platelet-Rich Plasma Preparations in a Single-Donor Model. Arthrosc. J. Arthrosc. Relat. Surg. 2014;30:629–638. doi: 10.1016/j.arthro.2014.02.020.
    1. Degen RM, Bernard JA, Oliver KS, Dines JS. Commercial Separation Systems Designed for Preparation of Platelet-Rich Plasma Yield Differences in Cellular Composition. HSS J. 2017;13:75–80. doi: 10.1007/s11420-016-9519-3.
    1. Harmon, K. et al. Guidelines for the Use of Platelet Rich Plasma. (2011).
    1. Scully D, Naseem KM, Matsakas A. Platelet biology in regenerative medicine of skeletal muscle. Acta Physiol. 2018;223:e13071. doi: 10.1111/apha.13071.
    1. Sánchez, M. et al. PRP Injections in Orthopaedic Surgery: Why, When and How to Use PRP Dynamic Liquid Scaffold Injections in Orthopaedic Surgery. In Plasma Medicine - Concepts and Clinical Applications (InTech). 10.5772/intechopen.76091 (2018)
    1. Sánchez M, et al. Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration. Expert Opin. Biol. Ther. 2017;17:197–212. doi: 10.1080/14712598.2017.1259409.
    1. Chen Y-S, et al. Effects of Basic Fibroblast Growth Factor (bFGF)-Neutralizing Antibody and Platelet Factor 4 on Facial Nerve Regeneration. Exp. Neurol. 1999;155:274–283. doi: 10.1006/exnr.1998.6980.
    1. Oya T, et al. Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia. 2002;38:303–312. doi: 10.1002/glia.10074.
    1. McTigue DM, Popovich PG, Morgan TE, Stokes BT. Localization of Transforming Growth Factor-β1 and Receptor mRNA after Experimental Spinal Cord Injury. Exp. Neurol. 2000;163:220–230. doi: 10.1006/exnr.2000.7372.
    1. Özdinler PH, Macklis JD. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat. Neurosci. 2006;9:1371–1381. doi: 10.1038/nn1789.
    1. Farrag TY, Lehar M, Verhaegen P, Carson KA, Byrne PJ. Effect of Platelet Rich Plasma and Fibrin Sealant on Facial Nerve Regeneration in a Rat Model. Laryngoscope. 2007;117:157–165. doi: 10.1097/01.mlg.0000249726.98801.77.
    1. Kuffler DP. Platelet-Rich Plasma and the Elimination of Neuropathic Pain. Mol. Neurobiol. 2013;48:315–332. doi: 10.1007/s12035-013-8494-7.
    1. Sariguney Y, et al. Effect of Platelet-Rich Plasma on Peripheral Nerve Regeneration. J. Reconstr. Microsurg. 2008;24:159–167. doi: 10.1055/s-2008-1076752.
    1. Ding X-G, et al. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J. Androl. 2009;11:215–221. doi: 10.1038/aja.2008.37.
    1. Giannessi E, et al. An Autologously Generated Platelet-Rich Plasma Suturable Membrane May Enhance Peripheral Nerve Regeneration after Neurorraphy in an Acute Injury Model of Sciatic Nerve Neurotmesis. J. Reconstr. Microsurg. 2014;30:617–626. doi: 10.1055/s-0034-1372483.
    1. Park G-Y, Kwon DR. Platelet-rich plasma limits the nerve injury caused by 10% dextrose in the rabbit median nerve. Muscle Nerve. 2014;49:56–60. doi: 10.1002/mus.23863.
    1. Sánchez M, et al. Ultrasound-guided plasma rich in growth factors injections and scaffolds hasten motor nerve functional recovery in an ovine model of nerve crush injury. J. Tissue Eng. Regen. Med. 2017;11:1619–1629. doi: 10.1002/term.2079.
    1. Anitua E, et al. Plasma rich in growth factors (PRGF-Endoret) reduces neuropathologic hallmarks and improves cognitive functions in an Alzheimer’s disease mouse model. Neurobiol. Aging. 2014;35:1582–1595. doi: 10.1016/j.neurobiolaging.2014.01.009.
    1. Anitua E, Pascual C, Pérez-Gonzalez R, Orive G, Carro E. Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson’s disease. J. Control. Release. 2015;203:170–180. doi: 10.1016/j.jconrel.2015.02.030.
    1. Aboonq MS. Pathophysiology of carpal tunnel syndrome. Neurosciences (Riyadh). 2015;20:4–9.
    1. Saint-Lary, O., Rébois, A., Mediouni, Z. & Descatha, A. Carpal Tunnel Syndrome: Primary Care and Occupational Factors. Front. Med. 2, (2015).
    1. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 2010;10:1415–1426. doi: 10.1517/14712598.2010.514603.
    1. Andia I, Martin JI, Maffulli N. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin. Biol. Ther. 2018;18:389–398. doi: 10.1080/14712598.2018.1424626.
    1. Miller LE, Parrish WR, Roides B, Bhattacharyya S. Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: systematic review and meta-analysis of randomised injection-controlled trials. BMJ Open Sport Exerc. Med. 2017;3:e000237. doi: 10.1136/bmjsem-2017-000237.
    1. Zhou Y, Wang JH-C. PRP Treatment Efficacy for Tendinopathy: A Review of Basic Science. Studies. Biomed Res. Int. 2016;2016:1–8.
    1. Kia C, et al. Platelet-Rich Plasma: Review of Current Literature on its Use for Tendon and Ligament Pathology. Curr. Rev. Musculoskelet. Med. 2018;11:566–572. doi: 10.1007/s12178-018-9515-y.
    1. Chen X, Jones IA, Park C, Vangsness CT. The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing: A Systematic Review and Meta-analysis With Bias Assessment. Am. J. Sports Med. 2018;46:2020–2032. doi: 10.1177/0363546517743746.
    1. Yuan T, Zhang C-Q, Wang JH-C. Augmenting tendon and ligament repair with platelet-rich plasma (PRP) Muscles. Ligaments Tendons J. 2013;3:139–49. doi: 10.32098/mltj.03.2013.05.
    1. Zhang J, Middleton KK, Fu FH, Im H-J, Wang JH-C. HGF Mediates the Anti-inflammatory Effects of PRP on Injured Tendons. PLoS One. 2013;8:e67303. doi: 10.1371/journal.pone.0067303.
    1. Kim SJ, Lee SM, Kim JE, Kim SH, Jung Y. Effect of platelet-rich plasma with self-assembled peptide on the rotator cuff tear model in rat. J. Tissue Eng. Regen. Med. 2017;11:77–85. doi: 10.1002/term.1984.
    1. Andia I, Rubio-Azpeitia E, Maffulli N. Platelet-rich Plasma Modulates the Secretion of Inflammatory/Angiogenic Proteins by Inflamed Tenocytes. Clin. Orthop. Relat. Res. 2015;473:1624–1634. doi: 10.1007/s11999-015-4179-z.
    1. Jo CH, Lee SY, Yoon KS, Oh S, Shin S. Allogenic Pure Platelet-Rich Plasma Therapy for Rotator Cuff Disease: A Bench and Bed Study. Am. J. Sports Med. 2018;46:3142–3154. doi: 10.1177/0363546518800268.
    1. Kollitz KM, Parsons EM, Weaver MS, Huang JI. Platelet-Rich Plasma for Zone II Flexor Tendon Repair. HAND. 2014;9:217–224. doi: 10.1007/s11552-013-9583-9.
    1. Chahal J, et al. The Role of Platelet-Rich Plasma in Arthroscopic Rotator Cuff Repair: A Systematic Review With Quantitative Synthesis. Arthrosc. J. Arthrosc. Relat. Surg. 2012;28:1718–1727. doi: 10.1016/j.arthro.2012.03.007.
    1. de Vos RJ, et al. No effects of PRP on ultrasonographic tendon structure and neovascularisation in chronic midportion Achilles tendinopathy. Br. J. Sports Med. 2011;45:387–392. doi: 10.1136/bjsm.2010.076398.
    1. de Vos RJ, et al. Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy. JAMA. 2010;303:144. doi: 10.1001/jama.2009.1986.
    1. Krogh TP, et al. Treatment of Lateral Epicondylitis With Platelet-Rich Plasma, Glucocorticoid, or Saline. Am. J. Sports Med. 2013;41:625–635. doi: 10.1177/0363546512472975.
    1. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing Positive Effect of Platelet-Rich Plasma Versus Corticosteroid Injection in Lateral Epicondylitis. Am. J. Sports Med. 2011;39:1200–1208. doi: 10.1177/0363546510397173.
    1. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive Effect of an Autologous Platelet Concentrate in Lateral Epicondylitis in a Double-Blind Randomized Controlled Trial. Am. J. Sports Med. 2010;38:255–262. doi: 10.1177/0363546509355445.
    1. Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J. Shoulder Elb. Surg. 2011;20:518–528. doi: 10.1016/j.jse.2011.02.008.
    1. Schepull T, et al. Autologous Platelets Have No Effect on the Healing of Human Achilles Tendon Ruptures. Am. J. Sports Med. 2011;39:38–47. doi: 10.1177/0363546510383515.
    1. Chicharro-Alcántara D, et al. Platelet Rich Plasma: New Insights for Cutaneous Wound Healing Management. J. Funct. Biomater. 2018;9:10. doi: 10.3390/jfb9010010.
    1. Wroblewski AP, Mejia HA, Wright VJ. Application of Platelet-Rich Plasma to Enhance Tissue Repair. Oper. Tech. Orthop. 2010;20:98–105. doi: 10.1053/j.oto.2009.10.006.
    1. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Perspective Article: Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601. doi: 10.1111/j.1524-475X.2008.00410.x.
    1. Fernandez-Moure JS, et al. Platelet-rich plasma: a biomimetic approach to enhancement of surgical wound healing. J. Surg. Res. 2017;207:33–44. doi: 10.1016/j.jss.2016.08.063.
    1. Picard F, Hersant B, Bosc R, Meningaud J-P. The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: A review and a proposal for a new standard care. Wound Repair Regen. 2015;23:638–643. doi: 10.1111/wrr.12317.
    1. Picard F, Hersant B, Bosc R, Meningaud J-P. Should we use platelet-rich plasma as an adjunct therapy to treat “acute wounds,” “burns,” and “laser therapies”: A review and a proposal of a quality criteria checklist for further studies. Wound Repair Regen. 2015;23:163–170. doi: 10.1111/wrr.12266.
    1. Liao H-T, Marra KG, Rubin JP. Application of Platelet-Rich Plasma and Platelet-Rich Fibrin in Fat Grafting: Basic Science and Literature Review. Tissue Eng. Part B Rev. 2014;20:267–276. doi: 10.1089/ten.teb.2013.0317.
    1. Chellini F, Tani A, Zecchi-Orlandini S, Sassoli C. Influence of Platelet-Rich and Platelet-Poor Plasma on endogenous mechanisms of skeletal muscle repair/regeneration. Int. J. Mol. Sci. 2019;20:683. doi: 10.3390/ijms20030683.
    1. Miron RJ, et al. Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review. Tissue Eng. Part B Rev. 2017;23:83–99. doi: 10.1089/ten.teb.2016.0233.
    1. Mostafaei S, Norooznezhad F, Mohammadi S, Norooznezhad AH. Effectiveness of platelet-rich plasma therapy in wound healing of pilonidal sinus surgery: A comprehensive systematic review and meta-analysis. Wound Repair Regen. 2017;25:1002–1007. doi: 10.1111/wrr.12597.
    1. Tambella AM, et al. Platelet-rich plasma to treat experimentally-induced skin wounds in animals: A systematic review and meta-analysis. PLoS One. 2018;13:e0191093. doi: 10.1371/journal.pone.0191093.
    1. Parra F, Morales-Rome DE, Campos-Rodríguez R, Cruz-Hernández TR, Drago-Serrano ME. Effect of platelet-rich plasma on patients after blepharoplasty surgery. Orbit. 2018;37:81–86. doi: 10.1080/01676830.2017.1383453.
    1. Tsai H-C, Lehman CW, Chen C-M. Use of platelet-rich plasma and platelet-derived patches to treat chronic wounds. J. Wound Care. 2019;28:15–21. doi: 10.12968/jowc.2019.28.1.15.
    1. Tehranian, A. et al. Application of Autologous Platelet-Rich Plasma (PRP) on Wound Healing After Caesarean Section in High-Risk Patients. Iran. Red Crescent Med. J. 18, (2016).
    1. Huisstede BM, van den Brink J, Randsdorp MS, Geelen SJ, Koes BW. Effectiveness of Surgical and Postsurgical Interventions for Carpal Tunnel Syndrome—A Systematic Review. Arch. Phys. Med. Rehabil. 2018;99:1660–1680.e21. doi: 10.1016/j.apmr.2017.04.024.
    1. Kim P-T, Lee H-J, Kim T-G, Jeon I-H. Current Approaches for Carpal Tunnel Syndrome. Clin. Orthop. Surg. 2014;6:253. doi: 10.4055/cios.2014.6.3.253.
    1. Boonstra AM, Schiphorst Preuper HR, Balk GA, Stewart RE. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain. 2014;155:2545–2550. doi: 10.1016/j.pain.2014.09.014.
    1. Meirelles LM, et al. Evaluation of the Boston questionnaire applied at late post-operative period of carpal tunnel syndrome operated with the paine retinaculatome trhough palmar port. Acta Ortopédica Bras. 2006;14:126–132. doi: 10.1590/S1413-78522006000300002.
    1. Stuart Simpson, C. Hand Assessment: A Clinical Guide for Therapists. (APS Publishing, 2004).
    1. Geere J, Chester R, Kale S, Jerosch-Herold C. Power grip, pinch grip, manual muscle testing or thenar atrophy – which should be assessed as a motor outcome after carpal tunnel decompression? A systematic review. BMC Musculoskelet. Disord. 2007;8:114. doi: 10.1186/1471-2474-8-114.
    1. Ludlow, K. S., Merla, J. L., Cox, J. A. & Hurst, L. N. Pillar pain as a postoperative complication of carpal tunnel release: a review of the literature. J. Hand Ther. 10, 277–82.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅